Akiko T. Tateishi
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Immune checkpoint inhibitors in nuclear protein in testis carcinoma treatment: evidence of limited clinical benefits from a case series.
Journal: Japanese journal of clinical oncology
Published: October 03, 2025
Chromosome 15q15 Deletion Drives Brain Metastasis in NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: August 17, 2025
Prediction recurrence in stage I epidermal growth factor receptor-mutated non-small cell lung cancer using multi-modal data.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 03, 2025
Impact of weight loss on adverse events during chemoradiotherapy in patients with small cell lung cancer: a retrospective study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: June 12, 2025
Genomic Profiles of Pathogenic and Moderate-Penetrance Germline Variants Associated With Risk of Early-Onset Lung Adenocarcinoma.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 26, 2024
Implications of EGFR expression on EGFR signaling dependency and adaptive immunity against EGFR-mutated lung adenocarcinoma.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 03, 2024
Key Therapeutic Agents for Thymic Carcinoma in Real-world Clinical Practice.
Journal: Anticancer research
Published: October 27, 2024
Real-world outcomes of treatment strategy between first-line osimertinib, first/second-generation EGFR-TKIs followed by osimertinib and without osimertinib in advanced EGFR-mutant NSCLC.
Journal: ESMO real world data and digital oncology
Published: July 27, 2024
Association between lorlatinib blood concentration and adverse events and clinical impact of dose modification.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 15, 2024
Multi-omics and clustering analyses reveal the mechanisms underlying unmet needs for patients with lung adenocarcinoma and identify potential therapeutic targets.
Journal: Molecular cancer
Published: April 28, 2024
Mechanism of ERBB2 gene overexpression by the formation of super-enhancer with genomic structural abnormalities in lung adenocarcinoma without clinically actionable genetic alterations.
Journal: Molecular cancer
Published: August 21, 2023
Last Updated: 09/26/2026